Skip to content
POM-V Prescription Required Companion Animal

Tralieve 80 mg Chewable Tablets for Dogs

Active ingredient: Tramadol hydrochloride

Form

Chewable

Species

Dogs

Manufacturer

Dechra Regulatory BV

VMD MA No.

50406/5011

What it's used for

For the reduction of acute and chronic mild soft tissue and musculoskeletal pain.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Tramadol hydrochloride

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Tralieve 80 mg Chewable Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For the reduction of acute and chronic mild soft tissue and musculoskeletal pain.
The recommended dose is 2-4 mg tramadol hydrochloride per kg body weight every
8 hours or as needed based on the intensity of pain.
Minimum dosing interval is 6 hours. The recommended maximum daily dose is 16
mg/kg. As the individual response to tramadol is variable and depends partly on the
dosage, the age of the patient, individual differences in pain sensitivity and general
condition, the optimal dosing regimen should be individually tailored using the above
dose and re-treatment interval ranges. The dog should be examined regularly by a
veterinarian to assess if additional analgesia is subsequently required. Additional
analgesia can be administered by increasing the tramadol dose until the maximum
daily dose is reached, and/or by following a multimodal analgesic approach with the
addition of other suitable analgesics.
The most appropriate tablet strengths should be used in order to minimise divided
tablets to be kept until the next dosing.
Please note that this dosing table is intended as a guide for dispensing the veterinary
medicinal product at the high end of the dose range: 4 mg/kg bodyweight. It states
the number of tablets required to administer 4 mg tramadol hydrochloride per kg
bodyweight.
Body weight
Tramadol
80 mg
20 kg30 kg40 kg 50 kg60 kg
= ¼ Tablet = ½ Tablet = ¾ Tablet = 1 Tablet
Tablets can be divided into 2 or 4 equal parts to ensure accurate dosing. Place the
tablet on a flat surface, with its scored side facing up and the convex (rounded) side
facing the surface.
AN: 03516/2023 & 03514/2023
2 equal parts: press down with your thumbs on both sides of the tablet.
4 equal parts: press down with your thumb in the middle of the tablet.
Do not administer in conjunction with tricyclic antidepressants, monoamine oxidase
inhibitors and serotonin reuptake inhibitors.
Do not use in cases of hypersensitivity to tramadol or to any of the excipients.
AN: 03516/2023 & 03514/2023
Do not use in animals with epilepsy.
Dogs:
AN: 03516/2023 & 03514/2023
Common
(1 to 10 animals / 100 animals
treated):
Sedation
a,b
, Drowsiness
b
Uncommon
(1 to 10 animals / 1,000
animals
treated):
Nausea, VomitingRare
(1 to 10 animals / 10,000
animals treated):
Hypersensitivity reaction
c
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Convulsion
d
a
Mild.
b
Especially when higher doses are given.
c
The treatment should be discontinued.
d
In dogs with a low seizures threshold.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
The analgesic effects of tramadol hydrochloride may be variable. This is thought to
be due to individual differences in the metabolism of the drug to the primary active
metabolite O-desmethyltramadol. In some dogs (non-responders) this may result in
the veterinary medicinal product failing to provide analgesia. For chronic pain,
multimodal analgesia should be considered. Dogs should be monitored regularly by a
veterinarian to ensure adequate pain relief. In case of recurrence of pain or
insufficient analgesia the analgesic protocol may need to be reconsidered.

Special precautions for safe use in the target species:
Use with caution in dogs with renal or hepatic impairment. In dogs with hepatic
impairment the metabolism of tramadol to the active metabolites may be decreased
which may reduce the efficacy of the veterinary medicinal product. One of the active
metabolites of tramadol is renally excreted and therefore in dogs with renal
impairment the dosing regimen used may need to be adjusted. Renal and hepatic
function should be monitored when using this veterinary medicinal product.
Cessation of long-term analgesic therapy should be done gradually whenever
possible.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to tramadol or any of the excipients should avoid
contact with the veterinary medicinal product.
Tramadol may cause sedation, nausea and dizziness after accidental ingestion,
especially by children. To avoid accidental ingestion, particularly by a child, unused
tablet parts should be returned to the open blister space and inserted back into the
carton and kept in a safe place out of the sight and reach of children as they pose a
health risk to small children due to accidental ingestion. In case of accidental
ingestion, particularly by children, seek medical advice and show the package leaflet
or the label to the physician. In case of accidental ingestion by adults: DO NOT
DRIVE as sedation may occur.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.
Concomitant administration of the veterinary medicinal product with central nervous
system depressants, may potentiate the CNS and respiratory depressant effects.
Tramadol can increase the effect of drugs that lower the seizure threshold.
AN: 03516/2023 & 03514/2023
Drugs that inhibit (e.g. cimetidine and erythromycin) or induce (e.g. carbamazepine)
CYP450 mediated metabolism may have an effect on the analgesic effect of
tramadol. The clinical relevance of these interactions has not been studied in dogs.
The combination with mixed agonist/antagonists (e.g. buprenorphine, butorphanol)
and tramadol is not advisable, because the analgesic effect of a pure agonist may be
theoretically reduced in such circumstances.
See also section 3.3.
Do not store above 30°C.
Store in the original package in order to protect from moisture.
Not applicable
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.